Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications

被引：9

作者：

Borad, M. ^{[1
]}

Javle, M. ^{[2
]}

Shaib, W. L. ^{[3
]}

Mody, K. ^{[4
]}

Bergamo, F. ^{[5
]}

Harris, W. P. ^{[6
]}

Damjanov, N. ^{[7
]}

Macarulla, T. ^{[8
]}

Brandi, G. ^{[9
]}

Masi, G. ^{[10
]}

Busset, M. Droz Dit ^{[11
]}

Boncompagni, A. ^{[12
]}

Dimova-Dobreva, M. ^{[12
]}

Engelhardt, M. ^{[12
]}

Saulay, M. ^{[12
]}

Halfdanarson, T. R. ^{[13
]}

Knox, J. ^{[14
]}

Abou-Alfa, G. K. ^{[15
]}

Personeni, N. ^{[16
]}

Mazzaferro, V. ^{[17
]}

机构：

[1] Mayo Clin Canc Ctr, Dept Oncol, Scottsdale, AZ USA

[2] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA

[3] Emory Univ, Hematol & Oncol, Atlanta, GA USA

[4] Mayo Clin, Hematol & Oncol, Jacksonville, FL USA

[5] IOV Ist Oncol Veneto IRCCS, Dipartimento Oncol 1, Padua, Italy

[6] Univ Washington, Med, Med Ctr, Seattle, WA USA

[7] Univ Penn, Abramson Canc Ctr, Hematol & Oncol, Philadelphia, PA USA

[8] Vall Hebron Inst Oncol, Med Oncol, VHIO Cellex Ctr, Barcelona, Spain

[9] Univ Bologna, Med Oncol, IRCCS Azienda Osped, Bologna, Italy

[10] AOU Pisana Stabilimento Santa Chiara, Oncol Med, Pisa, Italy

[11] Fdn IRCCS, Hepatopancreatobiliary & Digest Surg, Ist Nazl Tumori Milano, Milan, Italy

[12] Basilea Pharmaceut Ltd, Dept Dev, Basel, Switzerland

[13] Mayo Clin, Dept Med Oncol, Rochester, NY USA

[14] Princess Margaret Canc Ctr, Oncol Med, Toronto, ON, Canada

[15] Mem Sloan Kettering Evelyn H Lauder Breast Ctr, Dept Med, New York, NY USA

[16] Ist Clin Humanitas, Dept Oncol & Hematol, Rozzano, Italy

[17] Fdn IRCCS, Oncol Med, Ist Nazl Tumori Milano, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.087

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

59P

引用

页码：S567 / S568

页数：2